We are currently upgrading our website. Please bear with us if you are experiencing any loading issues.
The Voice of MedTech in Asia
John Collings is President, Asia Pacific, for Stryker with responsibility for all divisions within the region. He started his career with Stryker in 2016 in the Joint Replacement division where he served in various sales and marketing leadership roles, first as General Manager of the United Kingdom and then progressing to Vice President and General Manager of Europe. He was appointed to President of Stryker Asia Pacific in 2020 after assuming leadership roles with increasingly expanded responsibilities.
John is focused on driving and developing high-performing teams across the region. Having lived and worked in seven different countries, John embraces diversity and inclusion. This lays the foundation in developing mission-driven, diverse and inclusive teams that has been key to Stryker’s success. Together with Stryker’s customers, the dynamic team delivers customer-centric and differentiated innovation that drives optimal patient outcomes.
John has over 20 years of experience in the medical technology and pharmaceutical industry. Prior to Stryker, John held various sales and commercial leadership roles in Abbott Diabetes Care and AstraZeneca.
In addition to his executive leadership position, John is also Chairman of the Asia Pacific Medical Technology Association (APACMed), the trade association representing the medical technology industry in Asia Pacific. Through APACMed, John and the Board of Directors bring together member companies and key industry stakeholders to jointly improve the standards of care for patients across the region through innovative collaborations and policy-shaping that advances healthcare access for patients.
John received a Bachelor of Biology from the University of Birmingham, and Master of Research in Neuroscience from the University of Manchester. He currently resides in Singapore with his family.
Probir has three decades of medical technology industry experience and has extensively worked across medical-surgical, interventional, clinical diagnostics, infectious diseases, ophthalmology, and nutrition domains.
Probir has been with Terumo Corporation since 2012 and is currently responsible for
overseeing its operations across Asia Pacific and India. As the Regional Leader of Asia Pacific & India, he spearheads Terumo’s investments into these emerging markets for purposeful talent and business strengthening, health system scaleup through various skill interventions, and driving the long-term strategy of Terumo in Asia Pacific.
Given his keen interest in policy shaping, Probir is actively engaged in advocacy and sits on the Board of Directors for the Asia Pacific Medical Technology Association (APACMed) and Medical Technology Association of India (MTaI).
Probir also has over a decade’s teaching experience, specifically around strategy, leadership
development, coaching and performance management. His passion towards MedTech sees him mentor start-ups and entrepreneurs.
Probir resides in Singapore and is a frequent visitor to all of the Asia Pacific markets and Japan.
Lam Chee Hong is the President and a Member of the Management Board of B. Braun Asia Pacific. As President, he is responsible for the Group’s pharmaceutical and medical technology business across the region.
Chee Hong begin his career with B. Braun in 1986 as a medical sales representative. In recognition of his leadership, versatility and business performance, he was continually entrusted with additional key responsibilities and ascended through the levels in the organisation to assume the most senior leadership role in B. Braun Asia Pacific.
Based in B. Braun’s regional headquarters in Penang, Malaysia, he also oversees B. Braun Group’s largest production sites in the world with over 7,700 employees.
Chee Hong graduated with a Bachelor of Economics from the University of Malaya. He is married and has two children.
Farhana Nakhooda, GM & SVP Health Catalyst, Asia Pacific, leads the overall vision and growth strategy of the Health Catalyst business across Asia Pacific. She is passionate about improving healthcare outcomes, access to care as well as decreasing healthcare costs across the APAC region. She has extensive experience with engagement at the intersection of medicine, technology, AI and analytics. Prior to joining Health Catalyst, Farhana was the IBM Healthcare & Life Sciences solutions leader for Asia Pacific for 18 years where she played a key role in digitally enabling healthcare transformation projects across Asia Pacific, Eastern Europe and Middle East/Africa. She has more than 25 years of international experience in the healthcare and life sciences industry as a medical researcher and as a subject matter expert. Farhana has a Bachelor of Science degree (with Honors), in which she majored in Biology and Biochemistry, at the University of British Columbia. She completed her MBA at Monash Mt Eliza Business School in Melbourne, Australia.
Feng Dong is the Vice President of Asia Region-Led Markets for the Global Regions. He has been in the medical and healthcare industry for more than 30 years, and since joining Medtronic in 2004, has held several strategic positions, most recently serving as the Vice President and Managing Director of Medtronic Korea and Vice President for the Peripheral Vascular Operating Unit (OU) in Japan.
He is strongly committed to the principles of diversity, equity, and inclusion and is a firm believer that fostering a culture of inclusivity and respect can create innovative teams and make a positive impact on the lives of our patients.
Born in China, Feng Dong holds a Bachelor of Medicine from the University of Chinese Medicine School and spent five years in orthopedics treating patients in China. In his free time, Feng Dong enjoying spending time with his family and staying active through badminton, running, hiking, mountaineering, and skiing.
Vy joined Varian, now a Siemens Healthineers company, in 1998 and has held leadership positions in regulatory affairs, quality and compliance. She has been key to sharpening Varian’s focus on cancer care through acquisitions and divestments, and also in the combination of Varian and Siemens Healthineers. Her areas of expertise include global regulation, ethics and trade.
Lance Little became the Managing Director, Region Asia Pacific for Roche Diagnostics in 2012. Prior to that, he was the Managing Director of Roche Diagnostics India (including the Indian sub-region). His experience as Managing Director extends to both Roche Diagnostics Thailand and Roche Diagnostics New Zealand.
Lance joined Roche in New Zealand in 1995 in the technical support and management division of Boehringer Mannheim’s Clinical Chemistry portfolio, before moving on to sales and marketing roles. He was appointed Managing Director of Roche Diagnostics Thailand in 2008 before returning to New Zealand to take up the role of Managing Director in 2009.
Lance started his career as a Medical Laboratory Scientist, specialising in Biochemistry at Auckland Hospital Laboratory in New Zealand. Following that, he spent some time managing the Automation Laboratory at Diagnostic Laboratories in Auckland.
Stephen Morse is our senior vice president and president, Asia Pacific, a role he has held since May 2022. In this role, Stephen leads the company’s business across the Asia Pacific region and is responsible for strategy, talent development, commercial operations and the delivery of business growth. Prior to this role, Stephen served as president, Boston Scientific Japan from July 2019 to April 2022, and group vice president and general manager, Cardiovascular and Rhythm Management, Boston Scientific Japan. Prior to these roles in Japan, Stephen served as vice president, global marketing, Rhythm Management. Stephen joined Boston Scientific in July 1998 as a field clinical representative in the Rhythm Management business, moving progressively through the organization in roles spanning sales, marketing, strategy, and commercial functions. Before joining Boston Scientific, Stephen was a captain in the United States Air Force. He holds a B.Sc. in Chemical Engineering from Michigan State University, an M.B.A. in Management from Colorado State University and an M.Sc. in Financial Economics from University of London.
Marc was born in South Africa and holds commerce degrees from The Cape Peninsula University of Technology and The University of South Australia.
Prior to joining Olympus, Marc held several management positions working for a variety of technology-focused companies, including Philips and LG Electronics. His career spans numerous countries and continents including South Africa, The United Kingdom, Europe, Australia, and most recently Singapore.
Marc commenced his career with Olympus in 2004 in Sydney Australia where he served as the Managing Director for Australia and New Zealand in the Consumer Imaging business. In 2013, Marc moved to Singapore, to take on the role as Division Director of the Consumer Imaging Business for Olympus Corporation of Asia Pacific.
In 2019, Marc was promoted to Chief Executive Officer of Olympus Corporation of Asia Pacific, with full strategic and operational responsibility for the APAC Region. In addition, he also concurrently serves as the Managing Director of Olympus Singapore and sits on the board of the Asia Pacific Medical Technology Association (APACMed).
To achieve the Olympus purpose of Making people’s lives healthier, safer and more fulfilling, Marc is focused on establishing Olympus APAC as a MedTech organization known for excellence throughout the region.
Marc is married with two children and enjoys spending time with his family and the occasional ultra-marathon or competitive swim.
Paul Tan is the Divisional Vice President, Asia Pacific of Abbott Vascular Division. Paul joined Abbott in 2014 as General Manager, China. He was promoted to Divisional Vice President & General Manager, Greater China in 2017 and to current role in September 2019. Prior to joining Abbott, Paul was General Manager, China for Molnlycke Health Care.
Paul has been in the healthcare industry for over 20 years and has held leadership positions in companies, including Genzyme Corporation as a Commercial Manager and Teleflex as General Manager of Greater China.
Paul holds a master’s degree in structural engineering from Tongji University and a master’s in business administration from China Europe International Business School (CEIBS).
Pavan Kumar Mocherla is the Executive Vice President and President Greater Asia at Becton Dickinson.
With a distinctive ability to handle both big and small teams, Pavan brings people management skills, strategic thinking, analytical ability, learning agility and action orientation to the teams and assignments he manages. Some of his most satisfying successes have been leading teams on accelerated growth trajectories.
Vishnu Kalra is Company Group Chairman, Johnson & Johnson MedTech Asia Pacific, where he leads the company’s efforts to bring the next generation of smarter, less invasive, and more personalized treatments to patients across the Asia Pacific Region.
In this role, Vishnu is responsible for the leadership of a diverse team of around 10,000 employees across market leading surgery, orthopaedics, and interventional solutions businesses in the company’s fastest-growing region.
Over his two-decade tenure at Johnson & Johnson, Vishnu has held diverse leadership positions across multiple functions, sectors, and industries. Most recently, he led as President of Johnson & Johnson’s surgery business, Ethicon, in the United States focusing on commercial strategy and execution. Previously, as Worldwide President of Wound Closure & Healing at Ethicon, Vishnu managed the global P&L and brand portfolio. His expertise also extends to Johnson & Johnson’s orthopaedics business, DePuy Synthes, where he spearheaded various platforms and regional markets, including a significant stint in South Asia, for 12 years. Additionally, Vishnu’s diverse experience includes a role as Managing Director for the Gulf Cooperation Council in the company’s Innovative Medicine business.
Armed with a wealth of experiences across multiple regions, Vishnu is an accomplished global healthcare leader, deeply connected to the dynamic and fast-growing Asia Pacific region. He is a passionate advocate for the power of diversity and is committed to fostering talent development. Vishnu champions a culture of empowerment, encouraging every individual to bring their unique perspectives and strengths to their roles daily.
Vishnu holds a Bachelor of Engineering from the University of Pune in
India, and a Master of Business Administration from the McGill University, Montreal in Canada
Punit Kohli is the Vice President, Asia Pacific, Fresenius Medical Care, responsible for the Care Enablement operations. Punit joined Fresenius Medical Care in 2015 and has over 30 years of experience in the healthcare industry, working with healthcare giants like Johnson & Johnson and Becton Dickinson in the diverse areas of surgery, infection prevention, diagnostics, bio sciences and renal. He has been actively involved in building new businesses in the surgical, diagnostic and renal space.
He is driven by a strong value system, passion for people & therapy development, customer and industry focus. He is a champion of building inclusion and diversity in the organisation.
Fresenius Medical Care is committed to enhancing renal care in Asia Pacific by upgrading dialysis practice with cutting edge dialysis therapy systems and other dialysis solutions. Through its dedicated care delivery arm, it is striving to provide quality dialysis delivery across Asia Pacific.
Punit is an alumnus of Delhi University, India with Bachelor in Biochemistry & Law and received Master in Management from Asian Institute of Management, Manila, Philippines.
APACMed provides a unifying voice for the medical devices and in-vitro diagnostics industry in Asia Pacific. Founded in 2014, APACMed strives to promote innovation and impact policy that advances healthcare access for patients.
© Asia Pacific Medical Technology Association Ltd. All rights reserved. Read Our Terms Of Use